ZY

Zymergen Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.05
-0.82
-5.91%
Opening 14:34 09/20 EDT
OPEN
13.24
PREV CLOSE
13.87
HIGH
13.55
LOW
12.90
VOLUME
485.17K
TURNOVER
--
52 WEEK HIGH
52.00
52 WEEK LOW
7.85
MARKET CAP
1.34B
P/E (TTM)
-4.8747
1D
5D
1M
3M
1Y
5Y
Materials sector weekly round-up: Lightwave Logic becomes top gainer; Nexa Resources at bottom
Basic materials were under pressure this week amid production declines in China and the U.S. government moving towards what could be one of the biggest changes to U.S. mining law
Seekingalpha · 2d ago
Zymergen Shareholder Notice
New York, New York--(Newsfile Corp. - September 17, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Zymergen Inc. ("Zymergen" or the "Company") (NASDAQ: ZY) and reminds investors of the Octob...
Newsfile Corp · 2d ago
Zymergen Inc. Stock: Berger Montague Investigates Securities Fraud Claims Against Zymergen (ZY); Lead Plaintiff Deadline is October 4, 2021
Philadelphia, Pennsylvania--(Newsfile Corp. - September 17, 2021) - Berger Montague is investigating securities fraud claims against Zymergen Inc. ("Zymergen" or the "Company"). The Firm is investigating these claims on behalf of investors who purchased Zy...
Newsfile · 3d ago
Zymergen Deadline Alert
New York, New York--(Newsfile Corp. - September 15, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Zymergen Inc. ("Zymergen" or the "Company") (NASDAQ: ZY) and reminds investors of the Octobe...
Newsfile Corp · 4d ago
Berman Tabacco Announces Upcoming Lead Plaintiff Deadline for Investors with Significant Losses in Zymergen Inc. (ZY)
Boston, Massachusetts--(Newsfile Corp. - September 14, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations against Zymergen Inc. ("Zymergen" or the "Company") (NASDAQ: ZY), a "biofacturin...
Newsfile · 6d ago
Is Zymergen (ZY) A Good Stock To Buy Now?
Baron Discovery Fund recently published its second-quarter commentary – a copy of which can be downloaded here. During the second quarter of 2021, the Baron Discovery Fund returned 6.07% (institutional shares). In comparison, the benchmark S&P 500 Index wa...
Insider Monkey · 6d ago
Baron Select Funds Buys RingCentral Inc, Spotify Technology SA, Zymergen Inc, Sells GDS ...
GuruFocus News · 6d ago
Solugen is making chemicals from sugar, not petroleum
Investors poured more than $350 million into Solugen, a sustainable chemicals start-up.
CNBC.com · 09/09 12:59
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ZY. Analyze the recent business situations of Zymergen Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ZY stock price target is 17.60 with a high estimate of 43.00 and a low estimate of 8.00.
EPS
Institutional Holdings
Institutions: 80
Institutional Holdings: 52.22M
% Owned: 51.00%
Shares Outstanding: 102.39M
TypeInstitutionsShares
Increased
0
0
New
80
52.22M
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Personal Products
-1.34%
Personal & Household Products & Services
-1.28%
Key Executives
Non-Executive Chairman/Independent Director
Jay Flatley
Co-Founder/Chief Scientific Officer/Director
Zach Serber
Co-Founder/Vice President
Jed Dean
Chief Financial Officer
Enakshi Singh
Chief Technology Officer
Aaron Kimball
Other
Aindrea Campbell
Other
Subodh Deshmukh
Other
Lincoln Germain
Other
Mina Kim
Lead Director/Independent Director
Sandra Peterson
Independent Director
Steven Chu
Independent Director
Christine Gorjanc
Independent Director
Travis Murdoch
Independent Director
Matthew Ocko
Independent Director
Rohit Sharma
No Data
About ZY
Zymergen Inc. integrates computational and manufacturing technologies to design, engineer, and optimize microbes for industrial applications. The Company has developed a platform that treats the genome as a search space, utilizing machine learning algorithms and advanced automation to identify genetic changes. The Company's biofacturing platform, is a fusion of biology, chemistry and technology, is built on a stack that integrates techniques in molecular biology, chemistry, materials science, lab automation systems, software applications, databases and machine learning algorithms. Its biofacturing platform is designed to identify and create biomolecules and insert genes into a host microbe that produces the desired biomolecules. The Company serves to chemicals and materials, agriculture, and pharmaceuticals industries. The Company's product pipeline includes Electronics, Consumer Care, and Agriculture.

Webull offers kinds of Zymergen Inc stock information, including NASDAQ:ZY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ZY stock methods without spending real money on the virtual paper trading platform.